Prevalence of obesity and diabetes in patients with schizophrenia.

about

Health care use, drug treatment and comorbidity in patients with schizophrenia or non-affective psychosis in Sweden: a cross-sectional study.

P2860

Q47150301-A086672F-7623-4FAF-B11D-55E5713FEBA2

P2860

Prevalence of obesity and diabetes in patients with schizophrenia.

Item

http://www.wikidata.org/entity/Q38598772

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Prevalence of obesity and diabetes in patients with schizophrenia.

@en

type

Item

label

Prevalence of obesity and diabetes in patients with schizophrenia.

@en

prefLabel

Prevalence of obesity and diabetes in patients with schizophrenia.

@en

P1476

Prevalence of obesity and diabetes in patients with schizophrenia.

@en

P2093

Aniyizhai Annamalai

http://www.w3.org/2001/XMLSchema#string

Cenk Tek

http://www.w3.org/2001/XMLSchema#string

Urska Kosir

http://www.w3.org/2001/XMLSchema#string

P2860

An overview of diabetes management in schizophrenia patients: office based strategies for primary care practitioners and endocrinologists

Is the prevalence of metabolic syndrome and metabolic abnormalities increased in early schizophrenia? A comparative meta-analysis of first episode, untreated and treated patients

11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study).

Phenomenology of and risk factors for new-onset diabetes mellitus and diabetic ketoacidosis associated with atypical antipsychotics: an analysis of 45 published cases.

The association between first-episode psychosis and abnormal glycaemic control: systematic review and meta-analysis.

Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states

The effect of dietary and physical activity pattern on metabolic profile in individuals with schizophrenia: a cross-sectional study

Typical and atypical antipsychotics differentially affect long-term incidence rates of the metabolic syndrome in first-episode patients with schizophrenia: a retrospective chart review.

Metabolic syndrome in people with schizophrenia: a review.

Antipsychotic-induced weight gain in first-episode psychosis patients: a meta-analysis of differential effects of antipsychotic medications.

P304

390-396

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4239/WJD.V8.I8.390

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28861176

http://www.w3.org/2001/XMLSchema#string

P921

schizophrenia

P932

5561038

http://www.w3.org/2001/XMLSchema#string

Prevalence of obesity and diabetes in patients with schizophrenia.

about

P2860

P2860

Prevalence of obesity and diabetes in patients with schizophrenia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932